Reports on completed clinical bioe­quiv­a­lence studies

A series of reports on completed clinical trials of bioequivalence of drugs was prepared in a short time.

Drugs

• highly selective direct factor Xa inhibitor, two dosages;
• contraceptive combination drug (two studies);
• an antidepressant used in the treatment and prevention of depression of varying severity and treatment of OCD symptoms;
• a new combination drug of a Russian manufacturer intended for the treatment of HIV-1 infection in adult patients (non-nucleoside reverse transcriptase inhibitor (NNRTI), in combination with two nucleotide reverse transcriptase inhibitors.